NCT02384187View on ClinicalTrials.gov

Gabapentin Premedication and Adenotonsillectomy in Pediatric Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

August 31, 2015

Conditions
Post Operative Nausea and Vomiting (PONV)Adenotonsillectomy
Interventions
DRUG

Gabapentin as premedication

Patients will receive 0.3 ml/kg (16 mg/kg) oral gabapentin solution (Neurontin 50 mg/ml, Pfizer Pharmaceutical) as premedication two hours before the induction of anesthesia

DRUG

placebo

Patients will receive 0.3 ml/kg of a placebo solution identical in taste, shape and color to the study medication two hours before the induction of anesthesia.

Trial Locations (1)

11562

Kasr Al Ainy, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02384187 - Gabapentin Premedication and Adenotonsillectomy in Pediatric Patients | Biotech Hunter | Biotech Hunter